Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Pacific Biosciences of California, Inc. PACB |
BlackRock Inc. BLK |
22,865,948 7.700% |
-1,776,718 (-7.21%) |
Filing History |
| 2025-04-09 4:09 pm Sale |
2025-03-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Integrated Core Strategies (US) LLC | 2,204,044 0.700% |
-14,239,612 (-86.60%) |
Filing History |
| 2024-12-10 4:32 pm Purchase |
2024-12-04 | 13G | Pacific Biosciences of California, Inc. PACB |
Integrated Core Strategies (US) LLC | 16,443,656 6.000% |
4,046,919 (+32.65%) |
Filing History |
| 2024-11-26 8:27 pm Purchase |
2024-11-21 | 13G | Pacific Biosciences of California, Inc. PACB |
SoftBank Group Corp. | 20,451,570 7.500% |
20,451,570 (New Position) |
Filing History |
| 2024-11-14 5:52 pm Purchase |
2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB |
EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) | 20,307,880 7.500% |
20,307,880 (New Position) |
Filing History |
| 2024-11-14 5:48 pm Purchase |
2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB |
MADRONE CAPITAL PARTNERS LLC | 26,891,915 9.900% |
5,800,000 (+27.50%) |
Filing History |
| 2024-11-12 4:43 pm Unchanged |
2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 17,642,751 6.470% |
0 (Unchanged) |
Filing History |
| 2024-11-08 4:16 pm Purchase |
2024-11-04 | 13G | Pacific Biosciences of California, Inc. PACB |
Integrated Core Strategies (US) LLC | 12,396,737 4.500% |
12,396,737 (New Position) |
Filing History |
| 2024-11-04 10:47 am Sale |
2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 17,642,751 6.470% |
-9,146,748 (-34.14%) |
Filing History |
| 2024-02-13 4:15 pm Purchase |
2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
MADRONE CAPITAL PARTNERS LLC | 21,091,915 7.900% |
1,175,982 (+5.90%) |
Filing History |
| 2024-02-12 5:12 pm Sale |
2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Nikko Asset Management Americas, Inc. | 13,200,375 4.930% |
-965,818 (-6.82%) |
Filing History |
| 2024-02-09 06:42 am Sale |
2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Jackson Square Partners LLC | 9,704,766 3.630% |
-5,300,411 (-35.32%) |
Filing History |
| 2024-02-05 06:08 am Sale |
2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Sumitomo Mitsui Trust Group, Inc. | 13,200,375 4.930% |
-965,818 (-6.82%) |
Filing History |
| 2024-01-29 4:01 pm Purchase |
2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 34,504,273 12.900% |
8,812,592 (+34.30%) |
Filing History |
| 2024-01-24 5:23 pm Purchase |
2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
BlackRock Inc. BLK |
24,642,666 9.200% |
6,108,207 (+32.96%) |
Filing History |
| 2024-01-10 10:16 am Purchase |
2023-12-29 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 26,789,499 10.020% |
6,510,464 (+32.10%) |
Filing History |
| 2023-02-13 4:03 pm Purchase |
2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
MADRONE CAPITAL PARTNERS LLC | 19,915,933 8.800% |
3,000,000 (+17.73%) |
Filing History |
| 2023-02-13 3:54 pm Sale |
2023-02-14 | 13G | Pacific Biosciences of California, Inc. PACB |
Capital International Investors | 6,099,681 2.700% |
-6,006,637 (-49.62%) |
Filing History |
| 2023-02-10 1:48 pm Sale |
2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 25,691,681 11.360% |
-691,422 (-2.62%) |
Filing History |
| 2023-02-10 10:29 am Purchase |
2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Nikko Asset Management Americas, Inc. | 14,166,193 6.260% |
2,251,168 (+18.89%) |
Filing History |